Syria recorded 212 new HIV diagnoses during 2025, lifting the total number of registered living individuals with the virus to 1,538 since tracking began in 1990. Health officials stress that the numbers do not reflect a sudden epidemiological surge. Instead, the figures mirror expanded testing access, the return of citizens who previously received treatment abroad, and improved public health reporting mechanisms.
Antiretroviral Access Drives Returnee Registrations
The registration of these cases requires careful interpretation.
Continuity of Care for Repatriated Patients
Several returning individuals already knew their diagnosis and received treatment outside Syria. Upon their return, they contacted the Ministry of Health to secure continuous access to antiretroviral medications and specialized medical services.
Health officials emphasize that cumulative totals of living patients should not be conflated with annual transmission rates. A registered case represents an administrative entry into the healthcare system rather than the exact year of initial infection.
Confidentiality Fuels Voluntary Reporting
The rise in documented cases stems directly from enhanced epidemiological surveillance and stronger engagement between patients and public health infrastructure.
WHO Figures Point to Low Transmission Rates
Data from the World Health Organization characterizes national HIV reporting rates in Syria as low. WHO records show 470 individuals receiving antiretroviral therapy in 2024, while voluntary counseling and testing services reached 8,820 people.
Despite these expanded screening efforts, national reporting rates remained below one case per 100,000 residents across the preceding five-year reporting window.
Surveillance mechanisms operate primarily through pre-marital screening clinics, national blood bank testing protocols, and specialized Ministry of Health surveys focused on populations at higher risk of exposure.
These diagnostic checkpoints ensure that individuals unaware of their status are identified and linked to care at facilities like the specialized infectious disease diagnostic center in Damascus.